MiRus · Other
Revolutionizing medicine with safer, more durable implants and less invasive surgeries using proprietary Rhenium-based alloy MoRe®.
Amount
$1.5B
Round
Other
Valuation
—
Announced
May 2026
Investors
Lead investor
Notes
auto-discovered via firecrawl